Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
in vitro gene mutation study in bacteria
Remarks:
Type of genotoxicity: gene mutation
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: The study was conducted according to an appropriate OECD test guideline, and in compliance with GLP.

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2002
Report date:
2002

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 471 (Bacterial Reverse Mutation Assay)
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Remarks:
Freie und Hansestadt Hamburg, Behörde für Arbeit, Gesundheit uns Soziales, Germany
Type of assay:
bacterial reverse mutation assay

Test material

Constituent 1
Chemical structure
Reference substance name:
N-[3-(methoxydimethylsilyl)propyl]ethylenediamine
EC Number:
221-337-1
EC Name:
N-[3-(methoxydimethylsilyl)propyl]ethylenediamine
Cas Number:
3069-33-8
Molecular formula:
C8H22N2OSi
IUPAC Name:
(2-aminoethyl)[3-(methoxydimethylsilyl)propyl]amine
Details on test material:
- Name of test material (as cited in study report): VP 50991
- Physical state: colourless liquid
- Stability under test conditions: > 1 day (4°C, in the dark) if vehicle is free of water
- Storage condition of test material: at room temperature, dry, tightly closed, dark

Method

Target gene:
his operon
Species / strain
Species / strain / cell type:
S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and TA 102
Metabolic activation:
with and without
Metabolic activation system:
cofactor supplemented post-mitochondrial fraction (S9 mix), prepared from the livers of rats treated with Aroclor 1254.
Test concentrations with justification for top dose:
plate incorporation test: 10, 31.6, 100, 316, 1000 µg/plate
preincubation test: 3.16, 10, 31.6, 100, 316 µg/plate
Vehicle / solvent:
DMSO
Controls
Untreated negative controls:
no
Negative solvent / vehicle controls:
yes
True negative controls:
no
Positive controls:
yes
Positive control substance:
9-aminoacridine
2-nitrofluorene
sodium azide
cyclophosphamide
methylmethanesulfonate
other: 2-anthracene amide
Remarks:
+S9: CP (TA 100, TA 1535; 1500 µg/plate); 2-anthracene amide (TA 98, TA 102, TA 1537; 2 µg/plate); -S9: Sodium azide (TA 100, TA 1535; 10 µg/plate); MMS (TA 102; 1300 µg/plate); 2-NF (TA 98; 10 µg/plate); amino acridine (TA 1537; 100 µg/plate)
Details on test system and experimental conditions:
METHOD OF APPLICATION: in agar (plate incorporation); preincubation

DURATION
- Preincubation period: 60 min (only in preincubation test)
- Exposure duration: 48 h

NUMBER OF REPLICATIONS: 2 independent experiments with 3 plates/concentration.

DETERMINATION OF CYTOTOXICITY
- Method: reduction in the number of colonies and/or scarce background lawn
Evaluation criteria:
Cytotoxicity: reduction of colonies by more than 50%
Mutagenicity:
No significant effects: number of colonies after treatment with test substance is less than 2-fold the number of colonies of the solvent control.
Significant effects:
- number of colonies after treatment with test substance is at least 2-fold (TA 98, TA 100, TA 102) or 3-fold (TA 1535, TA 1537) the number of colonies of the solvent control (with statistical significance),
- and a significant concentration-releated effect is observed,
- positive results were reproducible and histidine independence of the revertants was confirmed.
Statistics:
Number of revertants: U-test according to MANN and WHITNEY
Trend test: Spearman´s rank correlation coefficient

Results and discussion

Test results
Species / strain:
S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and TA 102
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
not applicable
Positive controls validity:
valid
Additional information on results:
TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation: no

RANGE-FINDING/SCREENING STUDIES: In the preliminary test cytotoxicity was observed from 1000 µg/plate onwards.

ADDITIONAL INFORMATION ON CYTOTOXICITY:
Plate incorporation test:
Without S9: Cytotoxicity was observed at 1000 µg/plate in all strains, from 100 µg/plate onwards in test strain TA 102 and at concentrations of 316 and 1000µg/plate in test strains TA 1535 and TA 1537.
With S9: Cytotoxicity was observed at 1000 µg/plate in all strains and at 316 and 1000 µg/plate in test strains TA 102 and TA 1537.
Preincubation test:
Without S9: Cytotoxicity was observed at 316 µg/plate in all strains, but in the test strains TA 98, TA 102 and TA 1535 it was noticed at 100 and 316 µg/plate.
With S9: Cytotoxicity was observed at 316 µg/plate in strains TA 102, TA 1537, and TA 1535.
Remarks on result:
other: all strains/cell types tested
Remarks:
Migrated from field 'Test system'.

Any other information on results incl. tables

Table 1: Test results of main test 1 (plate incorporation).

With or without S9-Mix

Test substance concentration

Mean number of revertant colonies per plate in the plate incorporation test

(μg/plate)

(average of 3 plates±standard deviation)

 

Base-pair substitution type

Frameshift type

 

TA 100

TA1535

TA 102

TA98

TA1537

Solvent control

118.3±2.9

9.0±3.0

288.7±52.8

20.3±4.5

9.0±3.0

10

140.7±40.5

11.0±1.0

268.3±3.2

22.3±4.0

11.0±1.0

31.6

104.3±3.2

6.7±2.1

277.3±17.3

22.3±3.1

6.7±2.1

100

112.7±12.6

9.7±4.5

200.0±18.7#

20.7±0.6

9.7±4.5

316

122.3±2.5

15.3±5.5

207.7±56.5#

27.7±6.0

4.3±2.1

1000

96.3±11.0#

#

154.0±49.0#

#

1.0±1.0#

Positive controls, –S9

Name

sodium azide

sodium azide

methyl methane sulfonate (MMS)

2-nitrofluorene (2 -NF)

amino-acridine

Concentrations (μg/plate)

10

10

1300

10

100

Average of 3 plates±sd

1123.0±61.3

291.7±74.4

983±35

755.3±22.9

246.7±12.7

+

Solvent control

143.0±7.8

14.3±0.6

299.3±13.0

35.3±3.8

15.0±7.0

+

10

139.7±15.9

10.0±3.0

274.0±22.6

39.3±1.5

8.0±2.0

+

31.6

180.7±48.9

12.0±2.0

278.3±10.1

39.0±6.0

6.3±3.1

+

100

133.3±17.6

14.7±6.0

159.0±14.2

41.3±4.0

8.0±2.6

+

316

146.0±33.8

16.0±3.5

113.3±47.6#

27.0±7.9

9.0±1.7#

+

1000

110.7±35.2#

5.3±5.0#

#

5.7±1.5#

#

Positive controls, +S9

Name

cyclophosphamide (CP)

cyclophosphamide (CP)

2-anthracene amide

2-anthracene amide

2-anthracene amide

Concentrations (μg/plate)

1500

1500

2

2

2

Average of 3 plates±sd

413.3±27.3

240.0±27.6

1061.0±49.3

758.7±31.8

254.3±10

#: scarce background lawn


Table 2: Test results of main test 2 (preincubation test). 

With or without S9-Mix

Test substance concentration

Mean number of revertant colonies per plate in the preincubation test

(μg/plate)

(average of 3 plates±standard deviation)

 

Base-pair substitution type

Frameshift type

 

TA 100

TA1535

TA 102

TA98

TA1537

Solvent control

110.3±8.4

12.3±6.4

259.0±32.5

24.0±3.6

9.0±2.6

316

42.0±22.9#

0#

0#

5.0±5.0#

1.0±1.7#

100

97.3±7.1

18.7±4.9#

90.7±39.3#

14.0±5.6#

5.0±1.7

31.6

96.7±6.0

15.7±3.2

228.0±52.9

22.3±3.8

5.7±1.5

10

103.0±6.1

19.0±5.3

258.7±13.7

27.0±7.8

5.7±1.5

3.16

94.7±112.9

20.0±2.6

270.3±8.3

24.3±6.0

8.7±2.3

Positive controls, –S9

Name

2-nitrofluorene (2 -NF)

sodium azide (2 -NF)

methylmethane sulfonate (MMS)

2-nitrofluorene

amino-acridine

Concentrations (μg/plate)

10

10

1300

10

100

Average of 3 plates±sd

683.7±48.0

237.0±17.3

1076.3±97.2

683.7±48.0

287.3±48.2

+

Solvent control

102.3±13.1

12.7±2.5

336.0±67.1

49.0±10.1

11.3±3.5

+

316

106.0±5.3

12.0±4.4#

0#

28.3±1.2

0.3±0.6#

+

100

104.7±30.6

14.3±2.5

272.3±7.6

37.0±1.7

8.3±3.8

+

31.6

118.3±21.7

11.7±3.8

273.3±48.7

38.3±3.5

9.3±2.1

+

10

104.3±16.0

14.3±3.8

343.3±20.4

40.3±2.1

6.0±1.7

+

3.16

90.3±5.5

19.7±3.8

331.3±42.0

40.0±6.1

8.7±1.5

Positive controls, +S9

Name

cyclophosphamide (CP)

cyclophosphamide (CP)

2-anthracene amide

2-anthracene amide

2-anthracene amide

Concentrations (μg/plate)

1500

1500

2

2

2

Average of 3 plates±sd

1092.0±53.7

318±45.4

1101.0±94.0

676.0±252.0

283.3±58.5

#: scarce background lawn

 

Applicant's summary and conclusion

Conclusions:
Interpretation of results (migrated information):
negative

N-[3-(methoxydimethylsilyl)propyl]ethylenediamine has been tested for mutagenicity in bacteria, in a study which was conducted according to OECD 471 and in compliance with GLP. No evidence of a test substance related increase in the number of revertants was observed with or without metabolic activation in the plate incorporation and preincubation experiment. It is concluded that the test substance is negative for mutagenicity to bacteria under the conditions of the test.